SCHEMBL4645575

SCHEMBL4645575

O=S(=O)(O)c1cc(-c2ccc(Cl)cc2)cc2c1OCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
IDH1 O75874 1/20 0.35
ERN1 O75460 2/20 0.34
NRP1 O14786 2/20 0.33
HSD11B1 P28845 1/20 0.33
GSK3B P49841 1/20 0.33
PARP1 P09874 2/20 0.33
IKBKB O14920 2/20 0.32
CHUK O15111 2/20 0.32
DYRK1A Q13627 1/20 0.32
MEN1 O00255 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TDP2 O95551 1/20 0.32
AHR P35869 1/20 0.32
XDH P47989 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
MLNR O43193 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649007 0.87 HSD17B1 (0.38) ERN1NRP1PARP1DYRK1AKMT2A
SCHEMBL4647930 0.86 PDE4B (0.40) NRP1PARP1IKBKBCHUKTDP2
SCHEMBL4646451 0.86 NRP1 (0.33) MAPTPKMERN1NRP1PARP1
SCHEMBL4648553 0.86 PARP1 (0.41) MAPTERN1NRP1PARP1IKBKB
SCHEMBL4648578 0.83 KIF11 (0.39) MAPTTDP2PTGS1PTGS2
SCHEMBL4647763 0.83 HSD17B1 (0.37) MAPTNRP1PARP1MEN1KMT2A
SCHEMBL4648461 0.83 XDH (0.44) PKMNRP1XDHSLC22A12PTGS2
SCHEMBL4649205 0.83 NPC1 (0.39) MAPTERN1GSK3BDYRK1APTGS1
SCHEMBL4648175 0.83 PTGS2 (0.35) ERN1NRP1PARP1DYRK1APTGS1
SCHEMBL4648162 0.82 NRP1 (0.40) PKMNRP1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR MAPT 4636/4885PKM 3288/4885IDH1 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.